We are live on
!
Find out more
SBK
Steven B. Klinsky Portfolio holdings
AUM
$220M
1-Year Est. Return
4.28%
This Fund
S&P 500
This Quarter
Est. Return
-3.13%
1 Year Est. Return
-4.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$37.2M
(+20%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
23.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
+$50.4M |
| 2 |
New Mountain Finance
NMFC
|
+$953K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.25% |
Similar funds
R
LG
F
PIM
RP
RRC
CRX
KAM
Steven B. Klinsky's Q1 2015 Portfolio in Review
As of Q1 2015, Steven B. Klinsky held 3 positions worth $219M, up 20% from $182M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Steven B. Klinsky deployed $51.4M of net new capital in Q1 2015, opening 1 new position and adding to 1 existing holding. Its largest new stake was Bellerophon Therapeutics, Inc.: 323,992 shares worth $44.6M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 27% a quarter earlier.
- Steven B. Klinsky's largest Q1 2015 buy was Bellerophon Therapeutics, Inc.: 323,992 shares worth $44.6M.
- Steven B. Klinsky added most to New Mountain Finance in Q1 2015, an estimated $953K increase.
- Steven B. Klinsky's ten largest holdings make up 100% of its $219M portfolio in Q1 2015.
- Steven B. Klinsky opened 1 new position and closed 0 in Q1 2015.
- Steven B. Klinsky's portfolio value rose 20% quarter-over-quarter to $219M.
Based on Steven B. Klinsky's 13F filing for Q1 2015, filed 15 May 2015.